NA
SRTS icon

Navellier & Associates’s Sensus Healthcare SRTS Stock Holding History

Navellier & Associates’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50,948
Closed -$265K – 299
2023
Q1 		$265K Sell
50,948
-73,269
-59% -$526K 0.06% 236
2022
Q4 		$922K Buy
124,217
+6,428
+5% +$58K 0.19% 115
2022
Q3 		$1.48M Sell
117,789
-2,516
-2% -$30.1K 0.33% 86
2022
Q2 		$924K Buy
120,305
+65,904
+121% +$553K 0.2% 116
2022
Q1 		$551K Buy
+54,401
New +$497K 0.09% 179

Other funds holding SRTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Navellier & Associates's SRTS Position: Q2 2023 in Review

Navellier & Associates sold out of Sensus Healthcare (SRTS) in Q2 2023, closing a stake of 50,948 shares — an estimated $265K sold.

Navellier & Associates first reported a position in SRTS in Q1 2022 and held it in 5 quarters. The position peaked at $1.48M in Q3 2022. 49 funds tracked by Wall St. Rank hold SRTS as of Q2 2023.

  • Navellier & Associates reported no remaining Sensus Healthcare position as of Q2 2023 after selling out during the quarter.
  • Navellier & Associates sold 50,948 Sensus Healthcare shares in Q2 2023, an estimated $265K.
  • Navellier & Associates first reported a position in Sensus Healthcare in Q1 2022 and held it in 5 quarters.
  • Navellier & Associates's Sensus Healthcare position peaked at $1.48M in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2023.

Based on Navellier & Associates's 13F filing for Q2 2023, filed 7 Aug 2023.